Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The NCT03651271 page now presents the completed Phase 2 study record, including its nivolumab/ipilimumab treatment plan, eligibility criteria, locations, and outcome measures, instead of an access-denied error.
    Difference
    65%
    Check dated 2026-11-08T06:37:07.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T04:56:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notification banner was added announcing an NIH transition from the term “Artificial Intelligence” to “Super Intelligence.” The clinical trial record continues to display a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-25T06:47:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T05:24:41.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T08:27:45.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating restricted access. The usual study information and navigation are replaced by an error page.
    Difference
    20%
    Check dated 2026-09-20T02:57:31.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.